Stoltmann Law Offices is investigating brokers at VFinance Investments and National Securities Corp who may have sold private placements of Biopharma stocks. If you were recommended or sold any of the following stocks by your VFinance or National Securities Corp broker, please contact us today.
Ventrus Biosciences
Avenue Therapeutics
TG Therapeutics, Inc.
Mustang Bio
Checkpoint Therapeutics Inc.
Keryx Biopharmaceuticals Inc.
Coronado Biosciences
Helocyte
Cellvation
Escala Therapeutics
Journey Medical Corporation
Cyprium Therapeutics
Caelum Biosciences
Fortress Biotech
These investments may not be suitable for all investors, and both VFinance and National Securities Corp may be liable for losses if the firms allowed their brokers to recommend them. We are Chicago-based securities attorneys who represent clients on a contingency fee basis only, in order to help them recover their investment losses. The call to us is free with no obligation, so please call today. Attorneys are standing by.
Disclaimer
The posting on this site are mere OPINIONS and NOT statements of fact in any way whatsoever. The information should not be relied upon and there have been no findings made against the firms or individuals referenced on this site. In addition, this Blog is made available for educational purposes only and incorporates information from the web as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this blog site you understand that there is no attorney client relationship between you and Stoltmann Law Offices (161 N Clark Street 16th Floor Chicago, IL 60601). The Blog opinions should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.
PLEASE NOTE THIS IS ADVERTISING AND IT IS NOT A NEWSPAPER ARTICLE OR POST FROM AN INDEPENDENT OR NON-BIASED, NEWS SITE, NEWS SOURCE OR NEWSPAPER.
